Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. <i>Cancers</i> 2021, <i>13</i>, 2540”

We greatly appreciate Dr. Stummer’s and Dr. Thomas’s interest in our study and their important comments [...]

Guardado en:

Detalles Bibliográficos
Autores principales:	Arthur Hosmann, Matthias Millesi, Lisa I. Wadiura, Barbara Kiesel, Petra A. Mercea, Mario Mischkulnig, Martin Borkovec, Julia Furtner, Thomas Roetzer, Stefan Wolfsberger, Joanna J. Phillips, Anna S. Berghoff, Shawn Hervey-Jumper, Mitchel S. Berger, Georg Widhalm
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	n/a Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/0d9d8a72da7e42ca955ce794633a79d8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:0d9d8a72da7e42ca955ce794633a79d8
record_format	dspace
spelling	oai:doaj.org-article:0d9d8a72da7e42ca955ce794633a79d82021-11-25T17:02:53ZReply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. <i>Cancers</i> 2021, <i>13</i>, 2540”10.3390/cancers132257052072-6694https://doaj.org/article/0d9d8a72da7e42ca955ce794633a79d82021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/22/5705https://doaj.org/toc/2072-6694We greatly appreciate Dr. Stummer’s and Dr. Thomas’s interest in our study and their important comments [...]Arthur HosmannMatthias MillesiLisa I. WadiuraBarbara KieselPetra A. MerceaMario MischkulnigMartin BorkovecJulia FurtnerThomas RoetzerStefan WolfsbergerJoanna J. PhillipsAnna S. BerghoffShawn Hervey-JumperMitchel S. BergerGeorg WidhalmMDPI AGarticlen/aNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5705, p 5705 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	n/a Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	n/a Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Arthur Hosmann Matthias Millesi Lisa I. Wadiura Barbara Kiesel Petra A. Mercea Mario Mischkulnig Martin Borkovec Julia Furtner Thomas Roetzer Stefan Wolfsberger Joanna J. Phillips Anna S. Berghoff Shawn Hervey-Jumper Mitchel S. Berger Georg Widhalm Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. <i>Cancers</i> 2021, <i>13</i>, 2540”
description	We greatly appreciate Dr. Stummer’s and Dr. Thomas’s interest in our study and their important comments [...]
format	article
author	Arthur Hosmann Matthias Millesi Lisa I. Wadiura Barbara Kiesel Petra A. Mercea Mario Mischkulnig Martin Borkovec Julia Furtner Thomas Roetzer Stefan Wolfsberger Joanna J. Phillips Anna S. Berghoff Shawn Hervey-Jumper Mitchel S. Berger Georg Widhalm
author_facet	Arthur Hosmann Matthias Millesi Lisa I. Wadiura Barbara Kiesel Petra A. Mercea Mario Mischkulnig Martin Borkovec Julia Furtner Thomas Roetzer Stefan Wolfsberger Joanna J. Phillips Anna S. Berghoff Shawn Hervey-Jumper Mitchel S. Berger Georg Widhalm
author_sort	Arthur Hosmann
title	Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. <i>Cancers</i> 2021, <i>13</i>, 2540”
title_short	Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. <i>Cancers</i> 2021, <i>13</i>, 2540”
title_full	Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. <i>Cancers</i> 2021, <i>13</i>, 2540”
title_fullStr	Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. <i>Cancers</i> 2021, <i>13</i>, 2540”
title_full_unstemmed	Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. <i>Cancers</i> 2021, <i>13</i>, 2540”
title_sort	reply to stummer, w.; thomas, c. comment on “hosmann et al. 5-ala fluorescence is a powerful prognostic marker during surgery of low-grade gliomas (who grade ii)—experience at two specialized centers. <i>cancers</i> 2021, <i>13</i>, 2540”
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/0d9d8a72da7e42ca955ce794633a79d8
work_keys_str_mv	AT arthurhosmann replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcentersicancersi2021i13i2540 AT matthiasmillesi replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcentersicancersi2021i13i2540 AT lisaiwadiura replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcentersicancersi2021i13i2540 AT barbarakiesel replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcentersicancersi2021i13i2540 AT petraamercea replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcentersicancersi2021i13i2540 AT mariomischkulnig replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcentersicancersi2021i13i2540 AT martinborkovec replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcentersicancersi2021i13i2540 AT juliafurtner replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcentersicancersi2021i13i2540 AT thomasroetzer replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcentersicancersi2021i13i2540 AT stefanwolfsberger replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcentersicancersi2021i13i2540 AT joannajphillips replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcentersicancersi2021i13i2540 AT annasberghoff replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcentersicancersi2021i13i2540 AT shawnherveyjumper replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcentersicancersi2021i13i2540 AT mitchelsberger replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcentersicancersi2021i13i2540 AT georgwidhalm replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcentersicancersi2021i13i2540
_version_	1718412756764327936

Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. <i>Cancers</i> 2021, <i>13</i>, 2540”

Ejemplares similares